HomeCONGRESS

CONGRESS

View Category
Day 3

UK TAVI Registry: Long-term results of TAVI in the UK

This record has been created in order to evaluate the results of percutaneous aortic valve replacement in...
solaci -
Learn More
Day 3

DISCOVER Trial: Results at one year of the new nonmetallic percutaneous aortic valve

Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not...
solaci -
Learn More
Day 3

POST -IT: The FFR modifies strategy in almost half of patients

The use of FFR to guide treatment showed improved outcomes in previous studies. However, there are few...
solaci -
Learn More
Day 3

REDUCE-HTN: safety and efficacy of new bipolar device for renal denervation

This study included 146 patients with resistant hypertension who were medicated with an average of 5.4 drugs....
solaci -
Learn More
Day 2

IBERIAN: appendage occlusion registry

The aim of this study was to observe the rate of thromboembolic and hemorrhagic events in a...
solaci -
Learn More
Day 3

ADVANCE II: Low incidence of permanent pacemaker for self -expandable valve

The incidence of permanent pacemaker implantation (PPM) is variable between the different series within 30 days of...
solaci -
Learn More
Day 3

SIMPLICITY HTN -3: subgroup analysis identifies potential confounders

Initial studies showed a blood pressure significant reduction to 3 years in patients with resistant hypertension, while...
solaci -
Learn More
Day 3

TITAN-AMI: Final results of bio-active coated stent

Previous studies suggest the excellent performance of the bioactive coated stent TITAN 2 compared with drug-eluting stents...
solaci -
Learn More